Correlation of preferentially expressed antigen of melanoma (PRAME) gene expression with clinical characteristics in acute leukemia patients
Background: Preferentially expressed antigen of melanoma (PRAME) gene is regularly overexpressed in acute leukemia (AL) and other malignant diseases which are recognized by human leucocyte antigen (HLA-24) located in the human chromosome of 22q11 coded by 509 amino acids. To rule out the PRAME gene...
Main Authors: | Arumugam, M. (Author), Kalal, A.A (Author), Krishna, R. (Author), Kulkarni, N.V (Author), Kumari N, S. (Author), Shetty, P. (Author), Shetty, R.A (Author), Shetty, V.V (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Science and Business Media Deutschland GmbH
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Meme kanserinde PRAME (preferentially expressed antigen of melanoma) ekspresyonunun prognostik önemi
by: Kubilay Dalcı, et al.
Published: (2020-09-01) -
PRAME gene expression profile in medulloblastoma
by: Tânia Maria Vulcani-Freitas, et al.
Published: (2011-02-01) -
Clinical Significance of the PRAME Gene Expression in Oncohematological Diseases
by: VA Misyurin
Published: (2018-01-01) -
Chemoresistance of PRAME-expressing melanoma cell can be resolved with help of bortezomib
by: V. A. Misyurin, et al.
Published: (2019-01-01) -
Ex vivo enrichment of PRAME antigen‐specific T cells for adoptive immunotherapy using CD137 activation marker selection
by: Koon H Lee, et al.
Published: (2020-01-01)